Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 122c
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Join SI Premium – FREE
Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($1.83), $1.22 worse than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
- ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
